West Carrollton woman pleads guilty in fiery OVI crash involving 3 luxury vehicles daytondailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from daytondailynews.com Daily Mail and Mail on Sunday newspapers.
The 50th Anniversary of Title IX - June 23, 2022 - Edition III - General News - News mpssaa.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mpssaa.org Daily Mail and Mail on Sunday newspapers.
Zai Lab Announces Financial Results for Second-half and Full-year 2020
March 01, 2021 07:00 ET | Source: Zai Lab Limited Zai Lab Limited Company to Host Conference Call and Webcast Today at 8:00 a.m. ET
SHANGHAI and SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today reported financial results for the second half and full year of 2020, along with corporate updates.
“2020 was another year of great accomplishment for Zai Lab,” said Dr. Samantha Du, Founder, Chairperson and Chief Executive Officer of Zai Lab. “We successfully launched ZEJULA for both second-line and first-line ovarian cancer and Optune for glioblastoma in China. We submitted NDAs and were granted priority reviews by China’s National Medical Products Administration (NMPA) for both QINLOCK for advanced gastrointestinal stromal tumors (GIST) and NUZYRA for community-acquire